The limitations of specific adhesion and osteoblastic differentiation are current problems in bone tissue engineering. The aim of this study was to investigate the effect of a novel recombinant protein of fibronectin module III7-10/cadherin 11 EC1-2 (rFN/CDH) on cell adhesion and differentiation. Gene coding rFN/CDH was engineered by a homology modeling strategy, and an expression plasmid was constructed by standard DNA techniques. The rFN/CDH protein was expressed in Rosetta-gami (DE3), an improved Escherichia coli system. MC3T3-E1 cell centrifugal adhesive assay indicated that the adhesive capacity of rFN/CDH was significantly improved. Quantitative analysis of two osteogenic markers, osteocalcin mRNA expression and alkaline phosphatase activity, indicated that they were further up-regulated when human mesenchymal stem cells were cultured for 7-10 d on rFN/CDH pre-coated surfaces. These results suggest that rFN/CDH possesses an enhanced dual biofunctionality in osteoblastic adhesion and differentiation, and a promising application can be expected in biomimetic strategies and biomaterial development.
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Cell interactions with the extracellular matrix (ECM) and neighboring cells are essential to the maintenance of morphogenesis, development, homeostasis, and remolding of the skeletal system. 1, 2) These interactions involve direct cell-to-cell and cell-to-matrix recognition, adhesion, and organization, and they are also subject to regulation signals by different growth and differentiation factors from the ECM. 3, 4) Thus the ECM is not only a scaffold upon and within which tissues can organize, but is also an information reservoir that regulates cytoskeletal organization, cell growth behavior, and differentiation. Hence, the recognition and adhesion of osteocytes and bone ECM must be prerequisites of osteogenesis.
Among bone ECM proteins, fibronectin (FN) is present at the highest concentration during osteogenesis, and preferentially binds to osteoblasts more strongly than other ECM proteins, 5) such as collagen type I, vitronectin, and laminin. FN is a glycoprotein that is abundant in the ECM, and it participates in many cellular processes, including cell migration/adhesion, tissue repair, embryogenesis, and blood clotting. These diverse cellular responses are determined by the ability of fibronectin to bind to integrin, a family of heterodimeric transmembrane receptors. 6) Mature FN molecules are dimers of two C-terminally disulfidelinked monomers of 220 kDa. Each monomer consists of three homologous repeating units, known as the type I, II, and III domains. The type III FN domains (FNIII) form the largest and most important unit. The primary cell binding site of fibronectin is the RGD motif in the 10th type III module (FNIII10), which is specifically recognized by 5 1 -integrin. However, the addition of the FNIII9 module containing a site (PHSRN) that acts synergistically with FNIII10 results in near-maximum cell adhesion activity. 7) Following aggregation, cells form specialized cell junctions that stabilize these interactions and promote local communication between adjacent cells. This crosstalk between osteocytes can be enhanced by cadherin 11 (CDH 11), also known as osteoblast CDH (OB-CDH), a group of transmembrane proteins preferentially expressed in osteoblasts and characterized by the ''extracellular cadherin'' (EC) motif domain, termed EC1-EC5. 8) Unlike FN, CDH 11 mediates adhesive interactions with a homophilic binding specificity in a Ca 2þ -dependent manner. It typically mediates adhesion between neighboring osteoblasts and osteocytes and linkage to the actin filament network via the cytoplasmic binding partners -catenin, -catenin, and vinculin.
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y To whom correspondence should be addressed. Tel: +86-023-65216678; Fax: +86-023-68755608; E-mail: qiangx163@yahoo.cn Abbreviations: ECM, extracellular matrix; FNIII7-10, fibronectin module III7-10; CDH 11, cadherin 11; IPTG, isopropyl--D-thiogalactoside; SOE, splice-overlap extension; RT-PCR, reverse transcriptase-polymerase chain reaction; SDS-PAGE, sodium lauryl sulfate-polyacrylamide gel electrophoresis; LB, Luria-Bertani; MS, mass spectrometry; ALP, alkaline phosphatase; OCN, osteocalcin Currently, specific recognition and adhesion between seeding cells and scaffolds have long presented a limit to ossification in bone tissue engineering, and strong attempts have been made to solve this problem, such as surfaces prepared with oligopeptides, adhesive motifs mixtures, and high molecular weight ligands, but most of them were extremely challenging. Considering the different characteristics and contributions of FN and CDH 11 to osteoblastic adhesion and differentiation, we propose that proper integration of the bioactive fragments of FNIII7-10 and CDH 11 EC1-2 with a flexible peptide should result in a cooperative effect in cell adhesion and bone formation. Hence, this study aimed at the engineering and production of a novel recombinant FNIII7-10/CDH 11 EC1-2 protein (rFN/CDH) with the dual biocapacity of adhesion and differentiation that can be further used in biomaterial development for bone tissue engineering.
Materials and Methods
Gene engineering, cloning, splicing, and vector construction. The gene coding rFN/CDH was engineered by a homology modeling strategy based on simulations performed by SGI workstations, using the Insight II software package developed by Accelrys (San Diego, CA). Gene cloning and vector construction were implemented using standard DNA techniques. In brief, genes coding FNIII7-10 and CDH 11 EC1-2 were amplified by standard PCR with recombinant vectors carrying FNIII7-10 and CDH 11 DNA fragments as templates. The corresponding forward and reverse primers are listed in Table 1 . Both gene products were spliced by SOE-PCR, with annealing temperatures of 68 C for 10 cycles and 55 C for 25 cycles using a touchdown strategy. The purified product was then ligated to the pET-22b Sal I and Not I backbone fragment. Single recombinant vectors carrying the FNIII7-10 fragment and CDH 11 EC1-2 were constructed as positive controls in this study.
rFN/CDH production, purification, and identification. rFN/CDH was produced and purified using standard protein techniques. Briefly, the expression plasmids were transformed into competent DH5 and Rosetta-gami(DE3) cells. Rosetta-gami(DE3) transformed with cDNA coding rFN/CDH was streaked onto an LB agar plate containing 100 mg/ml of ampicillin, 15 mg/ml of kanamycin, 34 mg/ml of chloramphenicol, and 12.5 mg/ml of tetracycline, and this was incubated overnight at 37 C. One colony was isolated and dynamically cultured in 10 ml of LB broth with the same antibiotics as above for 3-5 h at 37 C when OD 600 reached 0.5-0.6. Concentrated bacterial culture (5 ml) was added to 500 ml of LB þ antibiotics þ 0.4 mM of IPTG, and cultured overnight at 30 C to induce rFN/CDH production (75 kDa). After centrifugation (12,000 g, 15 min, 4 C) and sonification (500 W, 2 min Â 5), the supernatant containing soluble rFN/CDH was purified by Ni-NTA affinity chromatography. The single fusion proteins of FNIII7-10 (45 kDa) and CDH 11 EC1-2 (35 kDa) were expressed and purified respectively, as the positive controls. rFN/CDH was further verified by mass spectrometry. Briefly, the protein bands corresponding to rFN/CDH were excised from the SDS-PAGE gels and destained twice. After dehydration in acetonitrile, reduction in DTT, and trypsinization, the resulting peptides were extracted and subjected to automatic separation and analysis in a HPLC-CHIP-MS/ MS system (Agilent, Boston, MA). The purified protein solution was sterilized to reduce the endotoxin content, which was released from the bacteria during the lysis step, using an Endotoxin Removal Kit for Protein Solution (Biovintage, San Diego, CA) prior to cell experiments.
Cell models. The mouse osteoblastic cell line MC3T3-E1 was cultured as described previously. 10) Briefly, the cells were cultured in -modified eagle's medium (MEM) supplemented with 10% fetal bovine serum (FBS), and were used prior to passage 20. Cultures were maintained at 70-80% confluence by refreshing every 2-3 d using standard techniques.
Human MSC were harvested from iliac crest aspirates of healthy human donors under local anesthesia solely for research purposes. MSC were prepared as previously described.
11) Briefly, mononuclear cells were isolated and cultured in Dulbecco's MEM (DMEM) supplemented with 20% FBS. After 72 h of incubation, the nonadherent cells were removed by replacing the medium. The plasticadherent MSC were split every 7 d to assess cell growth and cell yield. Different phenotypic markers of human MSC were employed to confirm the stem cell-like feature of the isolated cells. All the experiments were carried out on cells in passages 3-6. The experimental procedures were approved by the Institutional Review Board of the Third Military Medical University, and they also complied with the ethical principles of the World Medical Association.
Cell proliferation and viability assay. Cell proliferation and viability was assessed by Alamar Blue assay. Briefly, MSC were seeded onto the surfaces of tissue-culture treated polystyrene (TCPS) pre-coated with rFN/CDH solution (5 mg/ml), at a density of 2,000 cells/well in a TCPS 96-well plate. The cells were maintained in complete medium that was refreshed every 3 d. Proliferation and viability assay was performed at 1, 3, 5, 7 and 9 d. Then Alamar Blue (10 w/v% in PBS) was added to the cells, and 6 h later fluorescence was determined with a cytofluorometer (ex. 550 nm/em. 590 nm, Thermo Varioskam Flash, Boston, MA).
Centrifugal cell adhesive assay. Surfaces of TCPS 96-well plates were incubated with the purified rFN/CDH protein solution at a series of gradient concentrations (0, 2.5, 5, 10, 20, and 40 mg/ml) at 4 C for 12 h. They were then blocked with 1% 80 C-denatured bovine serum album (BSA) for 1 h. After trypsinization, centrifugation, and resuspension, the MC3T3-El cells were labeled with Hoechst-33342 (Biyuntian, Shanghai, China), a cell membrane permeable and DNAbinding fluorescent marker (ex. 360 nm/em. 451 nm), at 5 mg/ml in DPBS for 30 min. The cells were seeded onto substrates at 10,000 cells/well and centrifuged at 50 g for 5 min (Beckman Allegra X-22R centrifuge, Abbott Park, Illinois). After initial fluorescence readings were taken, the plates were immediately sealed, inverted, and centrifuged at 50 g for 5 min. Post-spin fluorescence readings were used to calculate the density of adherent cells. In addition, the cells were photographed with a Nikon TE-300 fluorescence microscope at a magnification of 100Â.
Real-time RT-PCR assays for osteocalcin (OCN). Surfaces of TCPS 6-well plates were incubated with the purified rFN/CDH protein solution at 5 mg/ml for 12 h and then blocked with 1% BSA for 1 h. The MSC were seeded and cultured on the pre-coated surfaces at 200 cells/well in growth medium. After 24 h, the cultures were maintained in osteogenic medium consisting of growth medium supplemented with 50 mg/ml of L-ascorbic acid and 10 mM sodium -glycerophosphate. Total RNA was isolated from 1 Â 10 6 MSC 7-10 d after cell seeding, using Trizol RNA extraction reagent (Invitrogen, Shanghai, China), according to the manufacturer's instructions. Reverse transcriptase (RT)-PCR assays were performed using 500 ng of standardized RNA (A260/280 ratio 1.8-2.0). The transcribed cDNA was amplified with primer pairs OCN and GAPDH (Table 1) . cDNA was analyzed via real-time PCR (ABI 7500 System, Applied Biosystems) using SYBR Green PCR reagents (Takara, Dalian, China).
ALP activity assay. The surfaces of TCPS 12-well plates and MSC were prepared as above. The treated cells were ultrasonicated for 1 min with 10 mM Tris/HCl buffer and 1 mM MgCl 2 (pH 7.4). After centrifugation, the supernatant was used to determine ALP activity, with paranitrophenyl phosphate as the substrate. The absorbance at 520 nm was measured in a 96-well spectrophotometer (Thermo Varioskam Flash, Boston, MA). The ALP activity (expressed as mmol nitrophenol/ min/mg) was normalized to the total intracellular protein content.
Statistical analysis. Experiments were performed at least in quadruplex, and results were expressed as the mean AE standard deviation. Student's T test was employed for statistical analysis using a two-tailed paired test, and the results were analyzed by paired analysis of variance. Statistical significance was reported as p < 0:05 for 95% confidence.
Results
Gene engineering, cloning, splicing, and vector construction A strategy of homology modeling was employed to simulate the 3D structures of the recombinant protein.
The results indicated that the framework of the Nterminal-CDH 11 EC1-2-(GlySer) 3 -FNIII7-10-C terminal was suitable for gene splicing. The amino acid sequence of rFN/CDH are listed in Table 2 . Under this condition, the four FN III modules presented as a rodlike structure. The RGD and PHSRN motifs protruded from the molecule and were on the same side, and this is identical to the crystal structure of natural FNIII7-10 (PDB ID:1FNF A) and is convenient for 5 1 -integrin binding. 12) Meanwhile, the ectodomain regions of CDH 11 were exposed outside, allowing the formation of adhesive dimers by exchange of the N-terminal strands between the partner EC1 domains 13, 14) (Fig. 1) . The genes encoding the FNIII7-10 and CDH 11 EC1-2 fragments were obtained by standard PCR techniques, which yielded 1.1-kbp and 0.8-kbp products respectively. After SOE-PCR with complementary primers, agarose gel electrophoresis showed that two DNA fragments were spliced into one product of 1.9 kbp (Fig. 2) . The SOE-PCR product was then ligated to linear pET22b and transformed into competent cell DH5 via electroporation. The plasmid DNA of the antibiotic-resistant colonies was digested with Sal I and Not I, and positive clones were identified by the presence of a 1.9-kbp fragment (Fig. 2) . DNA sequencing revealed a correspondence to the encoded nucleotides and corresponding amino acids, except for one nonsense mutation at 1023 (gaa ! gag, Glu ! Glu) (data not shown).
rFN/CDH production, purification, and identification Optimal expression of rFN/CDH was achieved in Rosetta-gami at 30 C with an OD value of 0.5-0.6, a final IPTG concentration of 0.4 mM, and an induction time of 4-6 h. The soluble and insoluble fractions were analyzed by SDS-PAGE. Coomassie Blue staining showed the induced protein at 75 kDa. This result is in agreement with the theoretical molecular weight (DNASTAR software, Madison, WI). The results also indicated that rFN/CDH was mainly expressed as soluble in the supernatant (60%), and composed of up to 32.9% of the total cell protein (Fig. 3) . After manipu- lation by nickel ion metal affinity chromatogaphy, the purity of the rFN/CDH reached 95% (Fig. 3) .
To determine the exact molecular weight and to further confirm the identity, purified rFN/CDH was subjected to MS analysis. The sequences of peptides derived from trypsin digestion were determined and searched for against a human database (ipi.HUMAN.v3.43.fasta). The results showed that the peptides correspond to a fibronectin precursor (Accession no. P02751, http://www. ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&-id= 2506872), according to the sequence map of a peptide (K)TGLD|S/PT/GI|D|F|SnDI|TnAnNnSnF(T), and to a CDH 11 isoform 1 of cadherin 11 precursor (Accession no. P55287, http://www.ncbi.nlm.nih.gov/entrez/ viewer.fcgi?db=protein&id=146345381), according to the sequence map of a peptide (R) SNV/GTSV|I/ Q|V|TA/S/D/A/D/D/PT/Y|G/NSnAK(L) (Fig. 4) .
Since endotoxins, such as lipopolysaccharide derived from gram-negative bacteria have a virulent influence on mammalian cells, they are closely associated with a series of biological dysfunctions, including release of negative cytokines and inflammatory factors, stimulation of osteoclast-cell differentiation resulting in bone resorption, and inhibition of osteoblatic cell differentiation for bone formation. 15, 16) Much attention was paid to removal of endotoxin from recombinant protein solution after purification. We used a rapid, easy-to-follow procedure and effectively reduced the endotoxin level to less than 0.2 EU for further use in cell experiments, according to the manufacture's instructions for the Endotoxin Removal Kit.
Cell proliferation and viability assay
To determine whether rFN/CDH has an influence on MSC growth, we examined the effect of rFN/CDH on MSC proliferation and viability by Alamar-Blue assay. The results showed that fluorescent values as an indicator of viable cell numbers did not change significantly when the cells were cultured on rFN/ CDH coated surfaces for 9 d, as compared with the cells cultured on pure TCPS surfaces. This result means that the protein did not change cell conditions of proliferation and viability.
Centrifugal cell adhesive assay
The fluorescence-labeled MC3T3-E1 cells were centrifuged to make contact with and detach from the surfaces pre-coated with rFN/CDH. This method can quantitatively determine the density of adherent cells. Our results suggest that rFN/CDH exhibited an enhanced capacity to adhere to MC3T3-E1 cells in a concentration-dependent manner, and that the optimal adhesive effect was acquired at a concentration of 5 mg/ml (Fig. 5a) . Moreover, significantly stronger effects were found in rFN/CDH than in the positive controls, with increases of 40% and 192% respectively. Images taken with a Nikon TE-300 fluorescence microscope are provided as a direct illustration of this phenomenon (Fig. 5b-e) .
OCN mRNA expression and ALP activity
The MSC used in this study were first confirmed by flow cytometry. The results indicated that these cells expressed different phenotypic markers of human MSC, a b including CD29, CD105, and CD45 (data not shown). To evaluate the effects of rFN/CDH on the expression of the differentiation markers of MSC towards osteoblasts, two classical osteogenic markers, OCN gene expression and ALP activity, were determined. We used quantitative real-time RT-PCR to probe osteoblastic gene expression in 7-10-d cultures of MSC cultured in osteogenic media to investigate effects of rFN/CDH on osteoblastic differentiation. The results indicated that OCN mRNA expression was 1.69-fold and 2.27-fold higher than that of the positive controls. Furthermore, a colorimetry-based assay also demonstrated that ALP activity was up-regulated with increases of 34% and 59%, as compared to those of FNIII7-10 and CDH 11 EC1-2 (Fig. 6) . Overall, these results suggested that rFN/CDH promoted differentiation of MSC towards an osteo-lineage, and that they might further induce the beginnings of ossification.
Discussion
Currently, ECM elements provide attractive characteristics worthy of mimicking to convey biofunctionality in cell functions, tissue structure, and regeneration.
17) The crucial effects of cell adhesion to ECM ligands have been implemented in numerous biotechnological and biomedical applications, including biomaterials, artificial organs, tissue engineering, etc. 18) In particular, biomimetic strategies focusing on the presentation of short oligopeptides, conformation-constrained peptides, and simple mixtures of adhesive motifs 8, 19, 20) have been found to be beneficial in controlling cell adhesion and differentiation, as in bone formation. Nevertheless, these bio-inspired strategies are limited by low activity and specificity. Alternatively, engineered high molecular weight ligands that recapitulate the primary, secondary, and tertiary structure of the native protein, such as FNIII7-10, FNIII9-10, 17, 21) have been found to possess adhesive activities similar to that of plasma FN. Extensive research has suggested that surfaces coated with a recombinant FNIII7-10 enhanced osteoblastic differentiation and mineralization in bone marrow stromal cell cultures and increased implant osseointegration in cortical bone models. 17, 18, 22) However, according to the results from our laboratory, the osteogenetic activity of FNIII7-10 was still marginally improved.
In addition to the adhesive responses associated with a single ligand, effects of multiple integrin subtypes binding to multivalent ECM were observed. Garcia et al. found that surfaces presenting mixed Collagen-I/ FN ligands synergistically enhanced focal adhesion kinase activation and promoted elevated proliferation rates. 23) This method significantly enhanced osteoblastic differentiation, but it was hard somewhat to manipulate. As an alternative, we introduced the CDH 11 key functional structure of EC1-2 to the backbone of FNIII7-10 to increase its capacity for osteoblast differentiation for a complementary effect of adhesive capacity. And as far as we know, the present study is the first to render the original molecular model for this strategy.
Cross-talk among bone cells is crucial for balanced bone remodeling, in which bone formation and bone resorption are coupled, allowing for the maintenance of bone mass. CDH 11 mediates cross-talk and interactions between the various cell types in bone, including the osteoblasts, osteocytes, osteoclasts, and macrophages, in a homophilic way. Related research has found that CDH 11 is highly expressed in osteoblastic cell lines and weakly expressed in osteoprogenitor cells. Its mRNA expression in osteoblastic cell lines is up-regulated during differentiation. 24) This phenomenon implies a specific function in bone cell differentiation and bone formation. Additionally, Kudo et al. found that CDH 11 directly regulates the differentiation of mesenchymal cells into cells of the osteo-lineage and the chondrolineage. 25) Crystallographic studies, electron micrographic research, and biochemical evidence confirm a dominant role for the EC1 domain. [26] [27] [28] Other studies of the structural basis of adhesion have shown that multiple EC domains might be involved in cadherin binding. 13, 29, 30) Additional studies and data from our lab indicate that expression of the EC domain of CDH 11 in vitro results in effective adhesion and in osteoblast differentiationrelated gene expression. 13, 31) Hence, in this study we integrated the DNA fragments of FNIII7-10 and CDH 11 EC1-2 structurally and biofunctionally to express a novel recombinant protein with dual enhanced capacity in osteoblastic adhesion and differentiation. Briefly, we spliced bioactive DNA fragments of FNIII7-10 and CDH 11 EC1-2 via SOE-PCR and expressed a novel recombinant protein, FNIII7-10/ CDH 11 EC1-2, in a prokaryotic system. Rosetta-gami (DE3) strains were used as expression strains, since they are designed for enhanced cytoplasmic disulfide bond formation as well as enhanced expression of eukaryotic proteins that contain codons rarely used in E. coli. Our results confirmed their convenience and utility in protein expression.
We then focused on testing the bioactivity of the recombinant protein by various methods in vitro. For adhesive analysis, the mouse osteoblastic cell line MC3T3-El was used as a cell model due to its expression of multiple integrins, especially 5 1 , their preference for adhesion to FN, and the necessity of adhesion to FN for differentiation. 32) The results showed that the adhesive capacity of this protein was obviously improved.
Osteogenesis is a complex process that involves the differentiation of mesenchymal cells into preosteoblasts and osteoblasts and ultimately leads to the synthesis and deposition of bone matrix proteins. 32) OCN mRNA expression and ALP activity, which are considered to be transient early osteo-differentiation markers in current works, 10) were determined in this study. The significant increase in OCN expression and ALP activity found in our study suggest that rFN/CDH promotes MSC differentiation and might further induce the beginnings of ossification.
As far as we know, the enhanced biofunctionality of rFN/CDH arises from coordination among fibronectin, integrin, and cadherin. This synergic regulation has been proved to be essential in cell-cell rearrangement and movement during tissue morphogenesis and development. For example, locking fibronectin-integrin ligation in Xenopus embryos reduces C-cadherin-mediated adhesion, promotes cell sorting, and inhibits cell intercalation. 33) Talin, a linker protein that connects integrins to the actin cytoskeleton, represses DE-cadherin transcription in Drosophila follicle cells and regulates DEcadherin-dependent localization of the oocyte in the egg chamber. 34) As for the signal pathways induced by integrin-mediated adhesion and differentiation, accumulating evidence suggests that fibronectin-integrin activated Src and FAK regulate the stability of the cadherincatenin complex, 35, 36) which is crucial in conversation between integrin and cadherin. These results suggest that the functions of fibronectin and cadherin are coordinately influenced by cell differentiation via complex transcriptional and signaling control. Nevertheless, the specific mechanism of the signal pathway and the way fibronectin and cadherin work together to contribute to osteoblastic adhesion and differentiation is worthy of further investigation.
Conclusion
In the present study, a novel recombinant protein was produced by a biomimetic strategy, and its effects on cell adhesion and osteoblast differentiation were investigated. The rFN/CDH expressed in this study conspicuously contributed to osteoblastic adhesion and differentiation. We set up an original molecular model of dual biofunctionality for osteoblastic adhesion and differentiation for the first time, and promising applications in biomimetic strategy, biomaterial design, and development with this recombinant protein can be expected, further research is needed.
